Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
暂无分享,去创建一个
Michael Shaw | Alicia M Fry | M. Shaw | L. Gubareva | A. Klimov | M. Levine | Tiffany G Sheu | V. Mishin | A. Fry | Alexander I Klimov | E. Ades | H. Nguyen | Ha T Nguyen | Alma A Trujillo | Marnie Levine | Vasiliy P Mishin | Edwin W Ades | Larisa V Gubareva | A. Trujillo
[1] L. Gubareva,et al. Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States , 2011, Emerging infectious diseases.
[2] L. Gubareva,et al. Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance , 2010, Antimicrobial Agents and Chemotherapy.
[3] Ji-Rong Yang,et al. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan. , 2010, Antiviral research.
[4] M. Zambon,et al. Rapid Quantitation of Neuraminidase Inhibitor Drug Resistance in Influenza virus Quasispecies , 2008, Antiviral therapy.
[5] Ha T. Nguyen,et al. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] T. Mehta,et al. Detection of Oseltamivir Resistance during Treatment of 2009 H1N1 Influenza Virus Infection in Immunocompromised Patients: Utility of Cycle Threshold Values of Qualitative Real-Time Reverse Transcriptase PCR , 2010, Journal of Clinical Microbiology.
[7] Arjun Srinivasan,et al. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. , 2011, The Journal of infectious diseases.
[8] Frederick Hayden,et al. Developing new antiviral agents for influenza treatment: what does the future hold? , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] Ha T. Nguyen,et al. Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro , 2010, Antiviral therapy.
[10] D. Operario,et al. Highly Sensitive and Quantitative Detection of the H 274 Y Oseltamivir Resistance Mutation in Seasonal A / H 1 N 1 Influenza Virus , 2010 .
[11] Ha T. Nguyen,et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective , 2010, Viruses.
[12] Ha T. Nguyen,et al. Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays , 2010, Antimicrobial Agents and Chemotherapy.
[13] R. Garten,et al. Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing , 2009, Antimicrobial Agents and Chemotherapy.
[14] Update: influenza activity--United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. , 2011, MMWR. Morbidity and mortality weekly report.
[15] Lynnette Brammer,et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. , 2009, JAMA.
[16] N. Saksena,et al. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. , 2010, Antiviral research.
[17] D. Operario,et al. Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza Virus , 2010, Journal of Clinical Microbiology.
[18] J. van de Kassteele,et al. Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season , 2009, Emerging infectious diseases.
[19] Michael Shaw,et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. , 2010, The New England journal of medicine.
[20] P. Simmonds,et al. The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.